Electromed, Inc. $ELMD

What the company doesAI summary of filing

Electromed, Inc. develops, manufactures, and sells the SmartVest System, a medical device that delivers high-frequency chest wall oscillation therapy to clear airways and mucus from the lungs in patients with compromised pulmonary function. The company is revenue-generating, with approximately $73.4 million in U.S. revenue in fiscal 2026, primarily from homecare sales through a direct-to-patient model where it manages insurance claims and delivers systems to patients' homes, supplemented by hospital sales. The SmartVest System is prescribed by physicians and reimbursed by Medicare, Medicaid, private insurance, and other payers under HCPCS code E0483, with Medicare's total allowable reimbursement at approximately $16,000 per unit. The company markets its products for patients with conditions including bronchiectasis, cystic fibrosis, and neuromuscular diseases, with the U.S. homecare HFCWO market estimated to be growing at approximately 8% annually. [10-K 2026-08-25]

Segments: SmartVest Clearway System, SmartVest SQL, Single Patient Use (SPU) SmartVest, SmartVest Wrap